Curtis Ruegg - Net Worth and Insider Trading

Curtis Ruegg Net Worth

The estimated net worth of Curtis Ruegg is at least $98,889 dollars as of 2024-11-13. Curtis Ruegg is the EVP, Technical Operations of Revance Therapeutics Inc and owns about 23,944 shares of Revance Therapeutics Inc (RVNC) stock worth over $98,889. Details can be seen in Curtis Ruegg's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Curtis Ruegg has not made any transactions after 2016-06-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Curtis Ruegg

To

Curtis Ruegg Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Curtis Ruegg owns 1 companies in total, including Revance Therapeutics Inc (RVNC) .

Click here to see the complete history of Curtis Ruegg’s form 4 insider trades.

Insider Ownership Summary of Curtis Ruegg

Ticker Comapny Transaction Date Type of Owner
RVNC Revance Therapeutics Inc 2016-06-13 EVP R&D and Tech Operations

Curtis Ruegg Latest Holdings Summary

Curtis Ruegg currently owns a total of 1 stock. Curtis Ruegg owns 23,944 shares of Revance Therapeutics Inc (RVNC) as of June 13, 2016, with a value of $98,889.

Latest Holdings of Curtis Ruegg

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RVNC Revance Therapeutics Inc 2016-06-13 23,944 4.13 98,889

Holding Weightings of Curtis Ruegg


Curtis Ruegg Form 4 Trading Tracker

According to the SEC Form 4 filings, Curtis Ruegg has made a total of 0 transactions in Revance Therapeutics Inc (RVNC) over the past 5 years. The most-recent trade in Revance Therapeutics Inc is the sale of 1,000 shares on June 13, 2016, which brought Curtis Ruegg around $18,250.

Insider Trading History of Curtis Ruegg

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Curtis Ruegg Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Curtis Ruegg Ownership Network

Ownership Network List of Curtis Ruegg

No Data

Ownership Network Relation of Curtis Ruegg

Insider Network Chart

Curtis Ruegg Owned Company Details

What does Revance Therapeutics Inc do?

Who are the key executives at Revance Therapeutics Inc?

Curtis Ruegg is the EVP R&D and Tech Operations of Revance Therapeutics Inc. Other key executives at Revance Therapeutics Inc include Chief Financial Officer Tobin Schilke , President Dustin S Sjuts , and SVP & GC & Secretary Dwight Moxie .

Revance Therapeutics Inc (RVNC) Insider Trades Summary

Over the past 18 months, Curtis Ruegg made no insider transaction in Revance Therapeutics Inc (RVNC). Other recent insider transactions involving Revance Therapeutics Inc (RVNC) include a net sale of 124,284 shares made by Mark J Foley , a net sale of 35,664 shares made by Tobin Schilke , and a net sale of 64,379 shares made by Dwight Moxie .

In summary, during the past 3 months, insiders sold 0 shares of Revance Therapeutics Inc (RVNC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 294,445 shares of Revance Therapeutics Inc (RVNC) were sold and 30,000 shares were bought by its insiders, resulting in a net sale of 264,445 shares.

Revance Therapeutics Inc (RVNC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Revance Therapeutics Inc Insider Transactions

No Available Data

Curtis Ruegg Mailing Address

Above is the net worth, insider trading, and ownership report for Curtis Ruegg. You might contact Curtis Ruegg via mailing address: 7555 Gateway Boulevard, Newark Ca 94560.